Fast Five Quiz: Are You Prepared to Confront Hepatitis C?

Vinod K. Dhawan, MD

Disclosures

June 04, 2021

The HCV NS3/4A protease inhibitor glecaprevir plus the HCV NS5A inhibitor pibrentasvir is one of two recommended regimens for simplified HCV treatment in eligible patients. The other recommended regimen is the NS5B polymerase inhibitor sofosbuvir plus velpatasvir, a HCV NS5A replication complex inhibitor. These drugs are among the available direct-acting antiviral agents for HCV therapy.

Learn more about the treatment of nonresponsive or relapsing HCV infection.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....